AVITA Medical Reports Q1 2026 Results: Revenue Up 4%, Net Loss Narrows, Reaffirms Full-Year Guidance
RCEL sits 43% above its 52-week low of $3.22.
Summary
AVITA Medical reported improved Q1 2026 financial results with revenue growth and reduced net loss, while reaffirming full-year guidance, despite continued cash burn.
Key Events · Earnings and Guidance · RCEL
-
Q1 2026 Financial Performance
Total revenue increased 4% year-over-year to $19.3 million, with operating expenses down 11% and net loss narrowing to $10.6 million.
-
Cash Position and Outlook
The company used $9.9 million in net cash, ending the quarter with $14.3 million, but anticipates a significant decrease in cash use for Q2.
-
Full-Year Guidance Reaffirmed
AVITA Medical reiterated its 2026 revenue guidance of $80 to $85 million, representing 12% to 19% growth.
-
Operational Progress
The company highlighted improved RECELL utilization, positive Cohealyx I data, and regulatory clearance for RECELL GO in Australia and New Zealand.
Analysis · RCEL · Industrial Applications And Services
AVITA Medical's first-quarter results show operational improvements with a 4% year-over-year revenue increase and an 11% reduction in operating expenses, leading to a narrower net loss. While the company experienced a $9.9 million net cash use, management expects this to significantly decrease in the second quarter and reaffirmed its full-year revenue guidance. These results provide an update on the company's financial health following a prior 'going concern' warning.
How filings like this one have moved
In the 30 days to Oct 1, 2026, 30.2% of the 1644 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was -0.49%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, RCEL was trading at $4.62 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $134.2M. The 52-week trading range was $3.22 to $7.19. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.